Theralase Technologies, Inc. (TLT.V)
0.285
+0.04
(+16.33%)
CAD |
TSXV |
Jan 12, 15:45
Theralase Technologies EPS Diluted (Quarterly): -0.004 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cannara Biotech, Inc. | 0.0362 |
| Biocure Technology, Inc. | -0.0029 |
| Core One Labs, Inc. | -- |
| Restart Life Sciences Corp. | -0.0059 |
| NanoSphere Health Sciences, Inc. | -0.0013 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.012M |
| Revenue (Quarterly) | 0.2796M |
| Total Expenses (Quarterly) | 1.292M |
| Enterprise Value | 63.22M |
| Gross Profit Margin (Quarterly) | 35.26% |
| Profit Margin (Quarterly) | -361.9% |
| Earnings Yield | -6.11% |
| Normalized Earnings Yield | -6.105 |